Clin Exp Otorhinolaryngol.  2022 May;15(2):125-126. 10.21053/ceo.2022.00612.

Application of Biologics in Treating Chronic Rhinosinusitis With Nasal Polyps in Asian Populations

• Kim DW
• Yang SK

• KMID: 2530157
• DOI: http://doi.org/10.21053/ceo.2022.00612

Reference

1. Stevens WW, Schleimer RP, Kern RC. Chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2016; Jul-Aug. 4(4):565–72.

2. Bachert C, Akdis CA. Phenotypes and emerging endotypes of chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2016; Jul-Aug. 4(4):621–8.

3. Yao Y, Zeng M, Liu Z. Revisiting Asian chronic rhinosinusitis in the era of type 2 biologics. Clin Exp Allergy. 2022; Feb. 52(2):231–43.

4. Zhang Y, Gevaert E, Lou H, Wang X, Zhang L, Bachert C, et al. Chronic rhinosinusitis in Asia. J Allergy Clin Immunol. 2017; Nov. 140(5):1230–9.

5. Kim SY, Park JH, Rhee CS, Chung JH, Kim JW. Does eosinophilic inflammation affect the outcome of endoscopic sinus surgery in chronic rhinosinusitis in Koreans. Am J Rhinol Allergy. 2013; Nov-Dec. 27(6):e166–9.

6. Calus L, Van Bruaene N, Bosteels C, Dejonckheere S, Van Zele T, Holtappels G, et al. Twelve-year follow-up study after endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyposis. Clin Transl Allergy. 2019; Jun. 9:30.

7. Kamath AV. Translational pharmacokinetics and pharmacodynamics of monoclonal antibodies. Drug Discov Today Technol. 2016; Sep-Dec. 21-22:75–83.

8. Bachert C, Han JK, Desrosiers M, Hellings PW, Amin N, Lee SE, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019; Nov. 394(10209):1638–50.

9. Lee Y, Kim ME, Nahm DH. Real clinical practice data of monthly dupilumab therapy in adult patients with moderate-to-severe atopic dermatitis: clinical efficacy and predictive markers for a favorable clinical response. Allergy Asthma Immunol Res. 2021; Sep. 13(5):733–45.